US Supreme Court Could Restore Generic Drug Skinny Label Certainty In Hikma-Amarin Review

 
• By Dave Wallace
  
The US Supreme Court has given the thumbs-up for the Hikma-Amarin certiorari review. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from United States